21
PRECLINICAL – ANIMAL STUDY Enny Rohmawaty Department Pharmacology and Therapy Faculty of Medicine-UNPAD

Preclinical – Animal Study

  • Upload
    yehudi

  • View
    93

  • Download
    0

Embed Size (px)

DESCRIPTION

Preclinical – Animal Study. Enny Rohmawaty Department Pharmacology and Therapy Faculty of Medicine-UNPAD. Preclinical study/preclinical trial. - PowerPoint PPT Presentation

Citation preview

Page 1: Preclinical – Animal Study

PRECLINICAL – ANIMAL STUDY

Enny RohmawatyDepartment Pharmacology and TherapyFaculty of Medicine-UNPAD

Page 2: Preclinical – Animal Study

Preclinical study/preclinical trial Preclinical trial - a laboratory test of a

new drug or a new medical device, usually done on animal subjects, to see if the hoped-for treatment really works and if it is safe to test on humans.

Page 3: Preclinical – Animal Study

• Pre-Clinical Trials and Clinical Trials are the processes by which scientists test drugs and devices to see if they are SAFE and EFFECTIVE.

Page 4: Preclinical – Animal Study

Experimental study In vitro and in vivo Animal models

Pharmacodynamic study

Toxicological study

Page 5: Preclinical – Animal Study

• PHARMACODYNAMIC STUDIES

Effects / Efficacy Mechanism of action • TOXICOLOGICAL STUDIES Safety Spectrum

Page 6: Preclinical – Animal Study

Pharmacodynamic study In vitro: tissue, cell culture, blood

component, etc In vivo : whole animal Disease model : inflammatory,

dislipidemi, sepsis, Ca/ malignancy, etc Source of methode (literature) :

Guidelines, journal

Page 7: Preclinical – Animal Study

Methodology of pharmacodynamic study

ANIMALS : Rodent or non-rodent (may depend on

desired effect) Healthy or diseased-animal model Sex : male and/or female Number : adequate for statistical analysis

Page 8: Preclinical – Animal Study

Sample size determination: Studies Comparing Two Group Means

To compute sample size for continuous variables, it is necessary to obtain an estimate of the population standard deviation of the variable (s) and the magnitude of the difference (d) the investigator wishes to detect, often called the effect.Sample size is given by

where s is the standard deviation, d is the difference to be detected, and C is a constant dependent on the value of and selected. C can be determined from the table above, which gives values for C for two levels of and . Note that for 0.05 and 1- 0.9, C is 10.51 and 2C would be 21

Ralph B. Dell, Steve Holleran, R Ramakhakrishnan, Sample sice determination, 2002

Page 9: Preclinical – Animal Study

Paired StudiesPaired studies compare values before and after an intervention in the same animal. In this case, data are analyzed by a paired t test, and the sample size is computed by

Ralph B. Dell, Steve Holleran, R Ramakhakrishnan, Sample sice determination, 2002

Page 10: Preclinical – Animal Study

If the s, d and C cannot be determined Federer’s Formula

(t-1) (n-1) ≥ 15 t = number of treatmentn = number of sample

Federer WT. Experimental design, theory and application, 1967.

Page 11: Preclinical – Animal Study

Data analysis Program : SPSS Normality and homogeneity test Quantitative and Qualitative test Post hoc analysis

Page 12: Preclinical – Animal Study

Route of administration : Per Oral- similar to human use

Dose : Based on Dose-Response Relationship One or more doses that provide a desired effect Dose conversion from human to animal may be used Calculation of ED50

Control group : Negative control

Solvent / vehicle group Positive control

Standard drug group To validate that a method works To obtain Relative Potency of drug candidate or herbal

medicines

Page 13: Preclinical – Animal Study

Toxicological studies IN VIVO TOXICOLOGICAL STUDIES

A. GENERAL TESTS SHORT TERM

Acute Toxicity Test (LD50) LONG TERM:

Sub Acute Test Sub Chronic Test Chronic Test

B. LOCAL TOXICITY TEST Dermatological Preparation

C. SPECIAL TOXICITY TESTS Mutagenicity Test Carcinogenicity Test Reproductive and Development Toxicity Test

Page 14: Preclinical – Animal Study

Animal models Animal models are, at the

best, analogous to human condition but no theory can be provided or refused by analogy. The truth is the evidence in animals can be a powerful device in support of virtually theory.

Page 15: Preclinical – Animal Study

l Why are animals necessary in research?1. Diseases process in human and animals have similarities 2. Cell systems contain or manipulate only a part of the organ system.3. Computer models lack the complexities of living entity .

Basic Reason Using Animals For Research

Page 16: Preclinical – Animal Study

WMA DECLARATION OF HELSINKI (Tokyo 2004)

BASIC PRINCIPLES FOR ALL MEDICAL RESEARCH

- Medical research involving human subjects must conform to generally accepted scientific principles, be based on a thorough knowledge of the scientific literature, other relevant sources of information, and on adequate laboratory and, where appropriate, animal experimentation.

- Appropriate caution must be exercised in the conduct of research which may effect the environment, and the welfare of animals used for research must be respected

Page 17: Preclinical – Animal Study

3R principles (Russell dan Burch, 1959)

Replacement

Reduction

Refinement

• correct model• genetic homogenity• use healthy animal

• Alternatifve methode• lower class of animal model

• caring• treatment• non-invasive methode• pain, stress, distress minimization

Page 18: Preclinical – Animal Study

Five Freedoms = Animal welfare

“The council believes that the welfare of an animal ... should be considered with reference to ‘Five Freedoms’.

Freedom from hunger and thirstFreedom from discomfortFreedom from pain, injury and diseaseFreedom to express normal behaviourFreedom from fear and distress(Farm Animal Welfare Council UK, 1993)

Page 19: Preclinical – Animal Study

Group housing when ever possible

Human interactions

Nesting materials

Enrichment Devices for NHP

Enrichment devices for rodents: Igloo, nest etc.

Page 20: Preclinical – Animal Study

Natural Behavior of burrowing & hiding

Page 21: Preclinical – Animal Study